tiprankstipranks
Shandong Xinhua Pharmaceutical Company Limited Class H (DE:XIN)
FRANKFURT:XIN
XIN
Shandong Xinhua Pharmaceutical Company Limited Class H
RESEARCH TOOLSreports

Shandong Xinhua Pharmaceutical Company Limited Class H (XIN) Revenue

2 Followers
StatisticsMarket CapRevenue

Shandong Xinhua Pharmaceutical Company Limited Class H Revenue

Shandong Xinhua Pharmaceutical Company Limited Class H had a revenue of 1.93B in the quarter ending Jun 30, 2026, with -20.50%. This bring the company's revenue in the last twelve months to 8.44B, Increased -3.24%. In the fiscal year ending Dec 31, 2025, Shandong Xinhua Pharmaceutical Company Limited Class H had annual revenue of 8.75B with 3.41% growth.
Revenue (ttm)
8.44B
Revenue Growth
-2.62%
P/S Ratio
0.11
Revenue/Employee
€1,209,216
Employees
7,240
Market Cap
€941.66M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
8.75B288.41M+3.41%
Dec 31, 2024
8.47B365.47M+4.51%
Dec 31, 2023
8.10B597.86M+7.97%
Dec 31, 2022
7.50B942.91M+14.37%
Dec 31, 2021
6.56B554.49M+9.23%
Dec 31, 2020
6.01B399.57M+7.13%
Dec 31, 2019
5.61B398.15M+7.65%
Dec 31, 2018
5.21B692.15M+15.33%
Dec 31, 2017
4.52B――